miR-449a inhibits colorectal cancer progression by targeting SATB2.
Sun X, Liu S, Chen P, Fu D, Hou Y, Hu J, Liu Z, Jiang Y, Cao X, Cheng C, Chen X, Tao Y, Li C, Hu Y, Liu Z, Zhan Y, Mao J, Wang Q, Ma Y, Cong X, Sun R, Shi Y, Wang M, Zhang X.
Sun X, et al. Among authors: liu z, liu s.
Oncotarget. 2016 Jul 28;8(60):100975-100988. doi: 10.18632/oncotarget.10900. eCollection 2017 Nov 24.
Oncotarget. 2016.
PMID: 29254139
Free PMC article.